Characterization of the First Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate Harboring blaSIM-1 from the United States
- PMID: 34339276
- PMCID: PMC8448160
- DOI: 10.1128/AAC.01066-21
Characterization of the First Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate Harboring blaSIM-1 from the United States
Keywords: Pseudomonas aeruginosa; antibiotic resistance; beta-lactamases; carbapenems; genome analysis; long-read sequencing.
Figures
References
-
- CDC. 2019. Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services, CDC, Atlanta, GA.
-
- Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier J-D, Rossolini GM, Chong Y. 2005. Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49:4485–4491. 10.1128/AAC.49.11.4485-4491.2005. - DOI - PMC - PubMed
-
- Lee K, Kim CK, Hong SG, Choi J, Song S, Koh E, Yong D, Jeong SH, Yum JH, Docquier J-D, Rossolini GM, Chong Y. 2010. Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-β-lactamases. Int J Antimicrob Agents 36:259–263. 10.1016/j.ijantimicag.2010.05.018. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
